The survival time of malignant rhabdomyosarcoma is related to the tumor site, stage, patient’s physical condition and treatment, etc. The survival period varies with the above conditions. The types of rhabdomyosarcoma are classified into embryonic type, glandular alveolar type and pleomorphic type. Embryonal rhabdomyosarcoma mainly occurs in infants and children, and has a short onset and rapid progression, with an average survival time of 16 months from the onset of the disease to death. Adenoid rhabdomyosarcoma, which occurs mainly in adolescents, also has a rapid progression and patients only survive for about 1 year. Polymorphic rhabdomyosarcoma, which occurs mainly in middle-aged and elderly people, usually grows in more muscular areas of the body and usually survives for about 5 years after the onset of symptoms, while a few elderly people with slow-growing tumors may survive for more than 20 years. Treatment of malignant rhabdomyosarcoma usually requires surgical resection, especially for embryonic type, and radiotherapy and chemotherapy on top of surgical resection.